Viewing Company Becton Dickinson | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Becton Dickinson Stock Symbol: BDX-N

Notes:disposable medical supplies

Last Price Recorded: $201.6700 on 2017-07-27

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-05-19 TOP PICK David Driscoll

This started a long time ago making syringes and needles, and that’s pretty much been their core. It’s all consumables in the hospitals, etc. Just made a recent acquisition of CR Bard (BCR-N) in the urology business. Both companies generate consistently growing free cash flows. There’s a 10% bump to the dividend every year. This merger is going to give them some debt that should be paid off within the next 2 years. He likes the company at this price.


Price:
$184.130
Subject:
GLOBAL
Bias:
UNKNOWN
Owned:
Yes
2011-11-21 PAST TOP PICK Mohsin Bashir (A Top Pick Aug 12/11. Down 8.41%.) Still likes. 38 consecutive years of dividend increases.
Price:
$71.840
Subject:
NORTH AMERICAN - LARGE
Bias:
UNKNOWN
Owned:
Yes
2011-11-02 BUY on WEAKNESS John O'Connell, CFA Disappointed earnings today so will be down tomorrow. Good dividend yield and trades at about 12X earnings. This is one you buy on weakness and average down. Good demographics.
Price:
$72.600
Subject:
NORTH AMERICAN - LARGE
Bias:
CAUTIOUS
Owned:
No
2011-08-12 TOP PICK Mohsin Bashir Medical technology. 38 years of consecutive dividend increases. Conservative payout ratio of 28%. 3 segments, medical, diagnostics and biosciences. All 3 have been growing at about 4%-5%. Met or exceeded earnings expectations for the last 5 years, usually 5%.
Price:
$80.280
Subject:
NORTH AMERICAN - LARGE
Bias:
UNKNOWN
Owned:
Yes
2011-01-20 PAST TOP PICK Laura Wallace (A Top Pick Dec 31/09. Up 7.42%.)
Price:
$83.090
Subject:
CANADIAN LARGE
Bias:
BULLISH on OIL
Owned:
Unknown
2010-07-14 BUY Gordon Reid Diagnostics is probably a good area to consider.
Price:
$69.590
Subject:
US EQUITIES
Bias:
CAUTIOUS
Owned:
Unknown
2010-05-13 TOP PICK Michael Simpson, CFA Medical devices. Selling into emerging markets where per capita spent on health care is very small. Generates a lot of free cash flow. Raised dividends over the last 37 years. Grown revenues from 2000 at 8% per year. Debt to cash flow is under 1X. Very stable business.
Price:
$74.470
Subject:
INCOME INVESTING
Bias:
BULL on US LARGE CAPS
Owned:
Yes
2009-12-31 TOP PICK Laura Wallace Hospital supply company in the US and will benefit when 40-50 million more people are covered under a healthcare plan. Trading at 13.5X earnings. Great growth record.
Price:
$78.860
Subject:
CANADIAN LARGE
Bias:
CAUTIOUS
Owned:
Yes
2009-12-15 TOP PICK Ara Nalbandian So shareholder friendly in all the actions they have taken. Dividends rising for 36 years in a row. No debt, buying back shares. Modest growth, likes sector and dividend, which grows.
Price:
$77.650
Subject:
NORTH AMERICAN - LARGE
Bias:
CAUTIOUS
Owned:
Yes
2009-07-08 BUY Gordon Reid Manufactures medical devices. Looking for it to earn about $5.50 next year. Very steady, highly predictable.
Price:
$68.670
Subject:
US EQUITIES
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Unknown
2009-03-31 BUY Brett Hryb Just recently purchased this. Has good revision and good valuation in the healthcare space. Products include syringes, monitors, catheters, etc. which healthcare services are in constant need of. Good growth and demand even when everything else is weak. Have some concerns on foreign exchange and margin issues because of increase in costs of raw materials. Expecting about 10% earnings growth in 2009, which is a great earnings profile.
Price:
$67.240
Subject:
US LARGE
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2009-02-06 BUY Charles Bobrinskoy If you go to a hospital in the US and look around, everywhere you go you see their products. There is a lot of concern that hospitals are not going to be able to spend the money that they have in the past so the stock has come down a long ways.
Price:
$74.090
Subject:
US EQUITIES
Bias:
CAUTIOUS
Owned:
No
2008-11-11 TOP PICK Laura Wallace Hospital supplies such as syringes, tests of blood supplies, etc. Off the radar on healthcare reform and pricing reform. Well diversified geographically with about 65% outside the US. Trading at 14 X earnings and looking at 12% growth.
Price:
$68.270
Subject:
CANADIAN LARGE
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2008-10-15 TOP PICK Laura Wallace Hospital supplies. 16-18% growth in earnings over the last 10 years and expected to do the same in the next 5. Not expected to be impacted by the health care costs in the US. Strong balance sheet.
Price:
$70.410
Subject:
CANADIAN LARGE
Bias:
SELECTIVELY OPTIMISTIC
Owned:
Yes
2008-06-18 BUY Laura Wallace Hospital supply company as well as doing a lot of diagnostics testing. Had disappointing performance in the near term, but she likes it longer term. Growing at 18% to 17% with 60% to 70% of its profits outside of North America.
Price:
$78.890
Subject:
NORTH AMERICAN - LARGE
Bias:
UNKNOWN
Owned:
Yes
Showing 1 to 15 of 26 entries
<< < 1 2 > >>

No Comments.


You must be logged in to comment.